| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/21/1995 | US5391755 Regulator of calcium homeostasis in animals; useful as therapeutic agent and treats malignancies |
| 02/21/1995 | US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses |
| 02/21/1995 | US5391564 E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents |
| 02/16/1995 | WO1995004817A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004751A1 Selectin binding glycopeptides |
| 02/16/1995 | WO1995004736A1 Process for the preparation of 9-amino camptothecin |
| 02/16/1995 | WO1995004735A1 Matrix metalloprotease inhibitors |
| 02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
| 02/16/1995 | WO1995004552A2 Radiometal complexes that localise in hypoxic tissue |
| 02/16/1995 | WO1995004548A1 Prostatic cancer vaccine |
| 02/16/1995 | WO1995004544A1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1995004541A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | WO1995004538A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/16/1995 | WO1995004526A1 Lupane triterpenoid derivatives |
| 02/16/1995 | CA2169291A1 Lupane triterpenoid derivatives |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2168950A1 Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 02/16/1995 | CA2168791A1 Matrix metalloprotease inhibitors |
| 02/16/1995 | CA2168652A1 Radiometal complexes that localise in hypoxic tissue |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168454A1 Selectin binding glycopeptides |
| 02/16/1995 | CA2167834A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
| 02/16/1995 | CA2142349A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/15/1995 | EP0638562A1 Anthraquinone derivatives useful in the treatment of cancer and osteoartritis |
| 02/15/1995 | EP0638553A1 Carboxylic acid amides having a terminal carboxylic acid group as aggregation inhibiting drugs |
| 02/15/1995 | EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 02/15/1995 | EP0638540A1 Pharmaceutical anthracene-2-carboxylic acid derivatives |
| 02/15/1995 | EP0638311A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0638080A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
| 02/15/1995 | EP0637964A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy. |
| 02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
| 02/15/1995 | EP0425507B1 Compositions and methods for treating skin conditions and promoting wound healing |
| 02/14/1995 | US5389683 Useful in treating or preventing a disorder of the melatoninergic system |
| 02/14/1995 | US5389644 For increasing sensitivity of tumor cells to antitumor agents without side effects |
| 02/14/1995 | US5389614 Anticoagulants |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | CA2129704A1 Pharmaceutical compounds |
| 02/14/1995 | CA2129692A1 Pharmaceutical compounds |
| 02/14/1995 | CA1334424C Thiochroman esters of phenols and terephthallates having retinoid-like activity |
| 02/14/1995 | CA1334414C Discorhabdin compositions and their methods of use |
| 02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
| 02/12/1995 | CA2128641A1 Stabilized solutions of platinum (ii) antitumor agents |
| 02/09/1995 | WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | WO1995004065A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | WO1995004060A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 02/09/1995 | WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004036A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/09/1995 | WO1995004033A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
| 02/09/1995 | WO1995003825A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/09/1995 | WO1995003814A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 02/09/1995 | WO1995003788A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | DE4325900A1 Trisubstituted pyrimido[5,4-d]pyrimidines for the modulation of multi-drug resistance, medicaments containing these compounds and processes for their production |
| 02/09/1995 | CA2168243A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | CA2167730A1 Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | CA2167671A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | CA2153236A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637319A1 A novel anti-neoplastic cytokine |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637310A1 Water-soluble retinoids |
| 02/08/1995 | EP0637300A1 Antiproliferative quinazolines |
| 02/08/1995 | EP0637299A1 20-methyl-substituted vitamin d derivates. |
| 02/08/1995 | EP0637297A1 Compounds having selectivity for retinoid x receptors |
| 02/08/1995 | EP0637246A1 Methods of treating cancer using modified c-reactive protein |
| 02/08/1995 | EP0637201A1 Method for inducing tumor immunity |
| 02/08/1995 | CN1098408A Heterocyclic inhibitors of farnesyl protein transferase |
| 02/07/1995 | US5387685 Bicyclic amines; resensitize multiple drug resistant cells to chemotherapeutic agents |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387609 Inhibiting ornithine decarboxylase activity |
| 02/07/1995 | US5387584 Bicyclic ansamycins |
| 02/07/1995 | US5387582 Vitamin D analogues |
| 02/07/1995 | US5387578 Releasing drugs from bioactive agents in order to improve the therapeutic efficacy and reduce their toxic effects |
| 02/07/1995 | US5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors |
| 02/06/1995 | CA2129374A1 Carbonamides, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/04/1995 | CA2129301A1 Benzo-fused heterocyclic compounds with a 5-membered ring, process for their preparation, their use as medicaments, their use as diagnostic agents, and medicaments containing them |
| 02/03/1995 | CA2129179A1 Trisubstituted pyrimido[5,4-d]pyrimidines for modulating multi-drug resistance, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003312A1 Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003283A1 Quinazoline derivatives and their use as anti-cancer agents |
| 02/02/1995 | WO1995003273A1 Vitamin d analogues |